Literature DB >> 21303345

Significance of P2X7 receptor variants to human health and disease.

Ronald Sluyter1, Leanne Stokes.   

Abstract

The human P2X7 receptor is a trimeric ligand-gated cation channel coded by the P2XR7 gene located at chromosome position 12q24. P2X7 is expressed in a wide variety of normal and disease-associated cell types. Activation of this receptor by extracellular adenosine 5'-triphosphate results in numerous downstream events including the release of pro-inflammatory mediators, cell proliferation or death, and killing of intracellular pathogens. As a result, P2X7 plays important roles in inflammation, immunity, bone homeostasis, neurological function and neoplasia. The P2XR7 gene encodes a P2X7 subunit 595 amino acids in length, however splice isoforms that can alter receptor expression and function, and modify the signaling properties downstream of receptor activation also exist. Moreover, the relative amount of P2X7 function varies between human individuals due to numerous single nucleotide polymorphisms resulting in either loss- or gain-of-function. Combinations of these polymorphisms give rise to various haplotypes that can also modify P2X7 function. Collectively, P2X7, and its splice and polymorphic variants are attracting considerable interest in relation to human health and disease, including the development and publication of a number of patents.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21303345     DOI: 10.2174/187221511794839219

Source DB:  PubMed          Journal:  Recent Pat DNA Gene Seq        ISSN: 1872-2156


  48 in total

1.  P2X7 receptor activation mediates organic cation uptake into human myeloid leukaemic KG-1 cells.

Authors:  Safina Gadeock; Aleta Pupovac; Vanessa Sluyter; Mari Spildrejorde; Ronald Sluyter
Journal:  Purinergic Signal       Date:  2012-06-05       Impact factor: 3.765

Review 2.  Central nervous system myeloid cells as drug targets: current status and translational challenges.

Authors:  Knut Biber; Thomas Möller; Erik Boddeke; Marco Prinz
Journal:  Nat Rev Drug Discov       Date:  2015-12-04       Impact factor: 84.694

Review 3.  The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases.

Authors:  Luca Antonioli; Corrado Blandizzi; Pál Pacher; György Haskó
Journal:  Pharmacol Rev       Date:  2019-07       Impact factor: 25.468

Review 4.  Expression and function of P2 receptors in hematopoietic stem and progenitor cells.

Authors:  Wenli Feng; Lina Wang; Guoguang Zheng
Journal:  Stem Cell Investig       Date:  2015-07-30

5.  The Roles of Mitochondrial Damage-Associated Molecular Patterns in Diseases.

Authors:  Kiichi Nakahira; Shu Hisata; Augustine M K Choi
Journal:  Antioxid Redox Signal       Date:  2015-08-17       Impact factor: 8.401

6.  High Level P2X7-Mediated Signaling Impairs Function of Hematopoietic Stem/Progenitor Cells.

Authors:  Wenli Feng; Feifei Yang; Rong Wang; Xiao Yang; Lina Wang; Chong Chen; Jinfeng Liao; Yongmin Lin; Qian Ren; Guoguang Zheng
Journal:  Stem Cell Rev Rep       Date:  2016-06       Impact factor: 5.739

Review 7.  Roles of extracellular nucleotides and P2 receptors in ectodomain shedding.

Authors:  Aleta Pupovac; Ronald Sluyter
Journal:  Cell Mol Life Sci       Date:  2016-05-14       Impact factor: 9.261

8.  CAY10593 inhibits the human P2X7 receptor independently of phospholipase D1 stimulation.

Authors:  A Pupovac; L Stokes; R Sluyter
Journal:  Purinergic Signal       Date:  2013-06-21       Impact factor: 3.765

9.  P2X7 receptor activation induces reactive oxygen species formation in erythroid cells.

Authors:  Bin Wang; Ronald Sluyter
Journal:  Purinergic Signal       Date:  2012-09-27       Impact factor: 3.765

10.  Signaling through purinergic receptors for ATP induces human cutaneous innate and adaptive Th17 responses: implications in the pathogenesis of psoriasis.

Authors:  Meaghan E Killeen; Laura Ferris; Erine A Kupetsky; Louis Falo; Alicia R Mathers
Journal:  J Immunol       Date:  2013-03-11       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.